CN Patent

CN101123946B — 改良含量均匀度的雷沙吉兰制剂

Assigned to Teva Pharmaceutical Industries Ltd · Expires 2013-06-26 · 13y expired

What this patent protects

公开了提高含量均匀度的R(+)-N-炔丙基-1-氨基二氢化茚的药物制剂、组合物的制备方法及其应用。

USPTO Abstract

公开了提高含量均匀度的R(+)-N-炔丙基-1-氨基二氢化茚的药物制剂、组合物的制备方法及其应用。

Drugs covered by this patent

rasagiline-mesylate (RASAGILINE MESYLATE)

Patent Metadata

Patent number: CN101123946B
Jurisdiction: CN
Classification: —
Expires: 2013-06-26
Drug substance claim: No
Drug product claim: No
Assignee: Teva Pharmaceutical Industries Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.